相关实验视频

Updated: Jun 28, 2025

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

Recognition of Epidermal Transglutaminase by IgA and Tissue Transglutaminase 2 Antibodies in a Rare Case of Rhesus Dermatitis

Published on: December 15, 2011

乳病:除了无质饮食之外的新治疗方法的希望

Maxim D'heedene¹, Tim Vanuytsel², Lucas Wauters²

¹University of Leuven, Belgium.

Clinical nutrition (Edinburgh, Scotland)

|April 22, 2024

概括

由于终身无质饮食 (GFD) 的挑战,正在探索治疗乳病 (CD) 的新疗法. 像ALV003和ZED-1227这样的有希望的选择正在开发中,旨在改善患者的治疗结果,而不仅仅是GFD.

科学领域:

胃肠道学和免疫学
药物开发药物开发

背景情况:

病 (CD) 是一种自身免疫性疾病,由摄入质引发.
目前的管理依赖于严格的无质饮食 (GFD),这提出了坚持挑战和生活质量问题.
耐火性CD病例需要替代和补充治疗,并改善患者的坚持治疗.

研究的目的:

审查乳病的新兴治疗策略.
为了确定除了无质饮食 (GFD) 外的新型治疗选择.

主要方法:

为了确定相关的临床试验,进行了系统的搜索.
审查重点关注的是I,II或III期临床试验中的治疗方法.

主要成果:

目前正在研究四种主要的治疗策略:谷蛋白排毒,调节肠道透性,增强免疫耐受性和调节谷蛋白自身免疫力.
迄今为止,还没有一种治疗乳病的方法完成了III期临床试验.

结论:

虽然没有新的治疗方法达到第三阶段,但正在进行的研究表明有希望.
未来的疗法可能会涉及无质饮食 (GFD) 的辅助药物.
ALV003和ZED-1227被确定为目前正在研究中的最有前途的治疗候选药物.

关键词:

结核病是什么? 结核病是什么?谷蛋白耐受性谷蛋白耐受性没有质的无质饮食.葡萄糖酶是什么葡萄糖酶是什么免疫治疗是一种免疫疗法.拉拉佐提德乙酸是一种

更多相关视频

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices

Validation of Therapeutic Agent Conjugation to Polyvinyl Alcohol-Coated Medical Devices

Published on: November 29, 2024

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

Analyzing Beneficial Effects of Nutritional Supplements on Intestinal Epithelial Barrier Functions During Experimental Colitis

Published on: January 5, 2017

相关概念视频

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...

Inflammatory Bowel Disease IV: Pharmacological Management

Inflammatory Bowel Disease IV: Pharmacological Management

Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...

Chronic Pancreatitis II: Collaborative Care

Chronic Pancreatitis II: Collaborative Care

The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.